Lack of PD-L1 Expression by iNKT Cells Improves the Course of Influenza A Infection
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lack of PD-L1 Expression by iNKT Cells Improves the Course of Influenza A Infection
Authors
Keywords
Influenza A virus, Cytokines, Influenza, Immune response, Inflammation, Respiratory infections, T cells, Flow cytometry
Journal
PLoS One
Volume 8, Issue 3, Pages e59599
Publisher
Public Library of Science (PLoS)
Online
2013-03-16
DOI
10.1371/journal.pone.0059599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Viral acute lower respiratory infections impair CD8+ T cells through PD-1
- (2012) John J. Erickson et al. JOURNAL OF CLINICAL INVESTIGATION
- Programmed death ligand 2 regulates arginase induction and modifies Trypanosoma cruzi survival in macrophages during murine experimental infection
- (2011) Laura R. Dulgerian et al. IMMUNOLOGY
- Viral infection prevents diabetes by inducing regulatory T cells through NKT cell–plasmacytoid dendritic cell interplay
- (2011) Julien Diana et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo
- (2011) A. M. Paterson et al. JOURNAL OF IMMUNOLOGY
- Potential Role of Invariant NKT Cells in the Control of Pulmonary Inflammation and CD8+ T Cell Response during Acute Influenza A Virus H3N2 Pneumonia
- (2011) C. Paget et al. JOURNAL OF IMMUNOLOGY
- Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity
- (2011) Ya-Jen Chang et al. NATURE IMMUNOLOGY
- Role of PD-L1 and PD-L2 in allergic diseases and asthma
- (2010) A. K. Singh et al. ALLERGY
- Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity
- (2010) Ya-Jen Chang et al. JOURNAL OF CLINICAL INVESTIGATION
- Antiviral CD8+T cell effector activities in situ are regulated by target cell type
- (2010) Matthew M. Hufford et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A CD1d-Dependent Antagonist Inhibits the Activation of Invariant NKT Cells and Prevents Development of Allergen-Induced Airway Hyperreactivity
- (2010) Vincent Lombardi et al. JOURNAL OF IMMUNOLOGY
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NKT cell immune responses to viral infection
- (2009) Marlowe S Tessmer et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions
- (2009) O Akbari et al. Mucosal Immunology
- Distinct subsets of human invariant NKT cells differentially regulate T helper responsesvia dendritic cells
- (2008) Tian-Yi Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection
- (2008) Ling‐Pei Ho et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
- (2008) Carmela De Santo et al. JOURNAL OF CLINICAL INVESTIGATION
- Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
- (2008) J. M. Coquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibodies and CD4+ T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain
- (2008) Karoline Droebner et al. VACCINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started